BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 942473)

  • 1. The effect of dibromo-dulcitol, diepoxy dulcitol and various new cytostatic hexitol derivatives on the metabolic activities of nucleic acids and proteins--II.
    Hidvégi EJ; Sebestyén J; Szabó LD; Köteles GJ; Institoris L
    Biochem Pharmacol; 1976 Aug; 25(15):1705-10. PubMed ID: 942473
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
    Fuzy M; Lelieveld P; Van Putten LM
    Eur J Cancer (1965); 1975 Mar; 11(3):169-73. PubMed ID: 165939
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of dibromo-dulcitol and dianhydro-dulcitol (galactitol) on RNA synthesis in ascites tumor cells.
    Fónagy A; Jeney A; Szamos J; Institóris L; Hidvégi EJ
    Acta Biochim Biophys Acad Sci Hung; 1981; 16(3-4):151-62. PubMed ID: 6182726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mannitol-myleran and two new dibromo-hexitols on the metabolic activities of nucleic acids and proteins. I.
    Hidvégi EJ; Lónai P; Holland J; Antoni F; Institoris L; Horváth IP
    Biochem Pharmacol; 1967 Nov; 16(11):2143-53. PubMed ID: 6076607
    [No Abstract]   [Full Text] [Related]  

  • 5. Complex evaluation of the effect of some cytostatic hexitol derivatives.
    Holczinger L; Somfai-Relle S; Institoris E; Gáti E; Turi G
    Oncology; 1980; 37 Suppl 1():104-8. PubMed ID: 7454197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of mannitol and sorbitol into dulcitol.
    BLADON P; OWEN LN
    Nature; 1949 Oct; 164(4170):567-9. PubMed ID: 18142452
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I and II studies with hexitol derivatives, formyl-leurosine and ftorafur.
    Eckhardt S
    Antibiot Chemother (1971); 1978; 23():50-7. PubMed ID: 348087
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of phenobarbital on the toxicity and antitumor activity of dibromodulcitol and dianhydrogalactitol.
    Gáti E; Somfai-Relle S
    Arzneimittelforschung; 1982; 32(2):149-51. PubMed ID: 7199919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic and antitumor effects of 1,2:5,6-dianhydrogalactitol (NSC-132313).
    Németh L; Institóris L; Somfai S; Gál F; Pályi I; Sugár J; Csuka O; Szentirmay Z; Kellner B
    Cancer Chemother Rep; 1972 Oct; 56(5):593-602. PubMed ID: 4652589
    [No Abstract]   [Full Text] [Related]  

  • 10. In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus.
    Nagarajan N; Yapp EKY; Le NQK; Yeh HY
    Mol Biol Rep; 2019 Jun; 46(3):3315-3324. PubMed ID: 30982214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects in rats of high oral doses of galactitol, mannitol and xylitol.
    Mäkinen KK; Hämäläinen MM
    J Nutr; 1985 Jul; 115(7):890-9. PubMed ID: 3925094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pseudourea (NSC-56054) on DNA, RNA, and protein synthesis in cultured cells.
    Finklestein JZ; Saarinen P; Karon M
    Cancer Chemother Rep; 1973; 57(4):399-403. PubMed ID: 4762438
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
    Horváth IP; Somfai-Relle S; Hegedüs L; Jarman M
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):573-7. PubMed ID: 6811281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The formation of 1,6-thioanhydrohexitols from the 1,6-di-O-mesyl derivatives of D-mannitol and galactitol.
    Jarman M; Griggs LJ
    Carbohydr Res; 1975 Nov; 44(2):317-20. PubMed ID: 1203909
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of lethal toxicity of chloroethylnitrosoureas by sugar alcohols without loss of antitumor activity.
    Tashiro T; Inaba M; Sakurai Y
    Cancer Chemother Pharmacol; 1982; 8(2):183-8. PubMed ID: 6809355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
    Csányi E; Halász M
    Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mode of action of the cytostatic 1,4-di-mesyloxyethylamino-1,4-dideoxy-m-erythritol (R-74).
    Csányi E; Elekes I
    Neoplasma; 1972; 19(3):189-98. PubMed ID: 5047464
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in electrolyte and iron metabolism in the rat in relation to peroral administration of galactitol, mannitol and xylitol.
    Hämäläinen MM; Mäkinen KK
    J Nutr; 1986 Apr; 116(4):599-609. PubMed ID: 3083056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell killing, kinetics, and recovery responses induced by 1,2:5,6-dianhydrogalactitol in dividing and nondividiing cells in vitro.
    Barranco SC; Flournoy DR
    J Natl Cancer Inst; 1977 Mar; 58(3):657-63. PubMed ID: 839561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.